449 related articles for article (PubMed ID: 34323939)
1. Prothrombotic immune thrombocytopenia after COVID-19 vaccination.
Tiede A; Sachs UJ; Czwalinna A; Werwitzke S; Bikker R; Krauss JK; Donnerstag F; Weißenborn K; Höglinger G; Maasoumy B; Wedemeyer H; Ganser A
Blood; 2021 Jul; 138(4):350-353. PubMed ID: 34323939
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on vaccine induced thrombotic thrombocytopenia.
Dotan A; Shoenfeld Y
J Autoimmun; 2021 Jul; 121():102663. PubMed ID: 34020254
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
[TBL] [Abstract][Full Text] [Related]
4. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
Scully M; Singh D; Lown R; Poles A; Solomon T; Levi M; Goldblatt D; Kotoucek P; Thomas W; Lester W
N Engl J Med; 2021 Jun; 384(23):2202-2211. PubMed ID: 33861525
[TBL] [Abstract][Full Text] [Related]
6. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
7. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia.
Panagiota V; Dobbelstein C; Werwitzke S; Ganser A; Cooper N; Sachs UJ; Tiede A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016324
[TBL] [Abstract][Full Text] [Related]
10. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.
Handtke S; Wolff M; Zaninetti C; Wesche J; Schönborn L; Aurich K; Ulm L; Hübner NO; Becker K; Thiele T; Greinacher A
Blood; 2021 Jul; 137(26):3656-3659. PubMed ID: 33945605
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
McGonagle D; De Marco G; Bridgewood C
J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
[TBL] [Abstract][Full Text] [Related]
12. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
Kenda J; Lovrič D; Škerget M; Milivojević N
J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
[TBL] [Abstract][Full Text] [Related]
13. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors.
von Hundelshausen P; Lorenz R; Siess W; Weber C
Thromb Haemost; 2021 Nov; 121(11):1395-1399. PubMed ID: 33851389
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea.
Choi JK; Kim S; Kim SR; Jin JY; Choi SW; Kim H; Yoo JH; Park IS; Kim SR
J Korean Med Sci; 2021 Aug; 36(31):e223. PubMed ID: 34402235
[TBL] [Abstract][Full Text] [Related]
16. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
[TBL] [Abstract][Full Text] [Related]
17. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.
De Michele M; Iacobucci M; Chistolini A; Nicolini E; Pulcinelli F; Cerbelli B; Merenda E; Schiavo OG; Sbardella E; Berto I; Petraglia L; Caracciolo N; Chiara M; Truglia S; Toni D
Nat Commun; 2021 Aug; 12(1):4663. PubMed ID: 34341358
[TBL] [Abstract][Full Text] [Related]
18. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
Kircheis R
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639132
[TBL] [Abstract][Full Text] [Related]
19. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
[TBL] [Abstract][Full Text] [Related]
20. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.
Thiele T; Ulm L; Holtfreter S; Schönborn L; Kuhn SO; Scheer C; Warkentin TE; Bröker BM; Becker K; Aurich K; Selleng K; Hübner NO; Greinacher A
Blood; 2021 Jul; 138(4):299-303. PubMed ID: 33988688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
